J
Jianjun Gao
Researcher at Qingdao University
Publications - 49
Citations - 3773
Jianjun Gao is an academic researcher from Qingdao University. The author has contributed to research in topics: Sorafenib & European union. The author has an hindex of 22, co-authored 49 publications receiving 3289 citations. Previous affiliations of Jianjun Gao include University of Tokyo & Shandong University.
Papers
More filters
Journal ArticleDOI
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
Jianjun Gao,Zhenxue Tian,Xu Yang +2 more
TL;DR: Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China.
Journal Article
Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer.
Fang-hua Qi,Anyuan Li,Yoshinori Inagaki,Jianjun Gao,Jijun Li,Norihiro Kokudo,Xiao-Kang Li,Wei Tang +7 more
TL;DR: This review provides evidence for use of Chinese herbal medicines as adjuvant cancer treatment during chemo- or radio-therapy and provides useful information for the development of more effective anti-cancer drugs.
Journal ArticleDOI
Biomarkers: Evaluation of Screening for and Early Diagnosis of Hepatocellular Carcinoma in Japan and China
Peipei Song,Jianjun Gao,Yoshinori Inagaki,Norihiro Kokudo,Kiyoshi Hasegawa,Yasuhiko Sugawara,Wei Tang +6 more
TL;DR: DCP can serve as a biomarker to detect HCC in an early stage and facilitate definitive treatment and the wide implementation of DCP is expected, especially in China where 55% of HCC cases worldwide live.
Journal ArticleDOI
Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection.
Fanghua Qi,Zhixue Wang,Pingping Cai,Lin Zhao,Jianjun Gao,Norihiro Kokudo,Anyuan Li,Junqing Han,Wei Tang +8 more
TL;DR: These Chinese herbal medicines exhibit significant anti-HBV activities with improved liver function, and enhanced HBeAg and HBsAg sero-conversion rates as well as HBV DNA clearance rates in HepG2 2.2.15 cells, DHBV models, or patients with CHB.
Journal ArticleDOI
Anti-tumor effects and cellular mechanisms of resveratrol.
TL;DR: Evidence of resveratrol's anti-tumor effects and molecular mechanisms are recapitulated and the anti-apoptosis, anti-invasion/metastasis and anti-inflammation effect of res veratrol is presented.